IMNM: Immunome, Inc.
Performance
IMNM +27.03%
Watchlist
Select an item
Summary
IMNM at a glance
IMNM returned +27.03% over the past year and -1.26% a year over five years. Its worst drop in that year was -44.78%, smaller than 30% of stocks on Redstone, and its Sharpe ratio of 0.64 beats 57% of stocks on Redstone. It pays no dividends.
Current Drawdown
-35.09%
Rolling Volatility
67.40%
Actions
Metrics
Risk Indicators
Alpha23.89%
Beta1.54x
Sharpe0.64
Sortino0.97
Omega1.12
Calmar0.60
Martin1.96
Profile
About IMNM
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.3B
- Listed
- Oct 2020
- Employees
- 177
- Headquarters
- Bothell, WA
- Website
- immunome.com
Comparisons